High-throughput screen to identify modulators of CendR-mediated cellular uptake
High-throughput screen to identify modulators of CendR-mediated cellular uptake
批准号:
8262597
负责人:
ERKKI RUOSLAHTI
金额:
$4.88万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-02-01 至 2014-01-31
关键词:
AffectAgonistAmino AcidsAntineoplastic AgentsArginineBindingBinding SitesBiochemicalBiologicalBiological AssayC-terminalCell LineCell Surface ReceptorsCell surfaceCellsChemicalsChemotherapy-Oncologic ProcedureCollaborationsCoupledDevelopmentDoseElementsFluorescence PolarizationGenomicsHomingIn VitroInfectious AgentInflammatoryLeadLibrariesLysineMediatingMolecularMolecular WeightMorphologic artifactsNamesNeuropilin-1NeuropilinsPathway interactionsPenetrationPeptidesPositioning AttributeProteinsProteolytic ProcessingSystemTissue SampleTissuesToxinTumor TissueValidationVenomsWorkbasecarboxyl grouphigh throughput screeninginnovationnanoparticlenovelnovel diagnosticsnovel therapeuticssmall moleculesmall molecule librariestooltumoruptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This application proposes high-throughput screening for small molecular weight compounds that mimic the internalizing and tissue-penetrating peptide motif R/KXXR/K (R=arginine; K=lysine; X=any amino acid). Peptides and proteins containing this motif activate a pinocytotic transport pathway into cells and through tissues by binding to a cell surface receptor, neuropilin-1. The R/KXXR/K motif has to be in a C-terminal position to bind to neuropilin; even blocking the C-terminal carboxyl group of the arginine residue eliminates the activity. Because of this feature, the motif has been designated the C-end Rule or CendR motif. Tumor- specific homing peptides that are internalized into cells and spread within tumor tissue contain both a specific tumor-homing sequence and a cryptic CendR motif, which is activated in tumors by proteolytic processing. A payload can either be covalently coupled to a CendR peptide or simply co-administered with it to achieve tissue penetration. Thus, the CendR pathway provides a way of overcoming one of the main limitations of cancer chemotherapy, poor penetration of anticancer drugs into tumor tissue. This pathway can also transport nanoparticles, enabling deep tissue delivery of nanoparticle payloads. Many inflammatory proteins, infectious agents and venoms possess proteins with CendR elements that may mediate entry into cells and spreading through tissues. Novel high-throughput assays that are based on the binding of a CendR peptide to a fragment of neuropilin-1 have been developed in collaboration with the Sanford-Burnham Center for Chemical Genomics, and a pilot screen using the assay has been successfully carried out. Larger screens are now proposed to assemble a panel of "hits". These molecules will be validated as specific modulators of the CendR pathway and their biological activity as agonists or antagonists of the CendR pathway will be determined assessed. The compounds resulting from this work that resemble the CendR peptides in their activity will be useful tools for introducing materials into cells and tissues, as well as for exploring the molecular basis of the CendR tissue penetration phenomenon. They may also serve as lead compounds in the development of novel diagnostic and therapeutic delivery systems. The screens may also yield antagonists of the CendR system, which could be useful in inhibiting the transport of toxins and infectious agents through the CendR transport system.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
New Molecular Signatures in Alzheimer's Disease
-
批准号:9317757
-
项目类别:
-
资助金额:$29.25万
-
财政年份:2017
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
A nanosystem for tumor treatment and imaging
-
批准号:9037631
-
项目类别:
-
资助金额:$40.46万
-
财政年份:2014
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
A nanosystem for tumor treatment and imaging
-
批准号:8693780
-
项目类别:
-
资助金额:$40.46万
-
财政年份:2014
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
High-throughput screen to identify modulators of CendR-mediated cellular uptake
-
批准号:8416337
-
项目类别:
-
资助金额:$4.73万
-
财政年份:2012
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
Tumor Penetrating Peptides for Cancer Targeting
-
批准号:8624663
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2011
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
Tumor Penetrating Peptides for Cancer Targeting
-
批准号:8266011
-
项目类别:
-
资助金额:$39.63万
-
财政年份:2011
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
Tumor Penetrating Peptides for Cancer Targeting
-
批准号:8815170
-
项目类别:
-
资助金额:$40.46万
-
财政年份:2011
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
Tumor Penetrating Peptides for Cancer Targeting
-
批准号:8446448
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2011
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
Tumor Penetrating Peptides for Cancer Targeting
-
批准号:8085532
-
项目类别:
-
资助金额:$39.63万
-
财政年份:2011
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
Injury-targeted decorin for systemic anti-fibrotic treatment
-
批准号:8199150
-
项目类别:
-
资助金额:$22.04万
-
财政年份:2011
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
Molecular Specialization of Tumor Lymphatics
-
批准号:7101746
-
项目类别:
-
资助金额:$17.64万
-
财政年份:2005
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
Molecular Specialization of Tumor Lymphatics
-
批准号:7417952
-
项目类别:
-
资助金额:$17.13万
-
财政年份:2005
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
Molecular Specialization of Tumor Lymphatics
-
批准号:7231979
-
项目类别:
-
资助金额:$17.13万
-
财政年份:2005
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
Molecular Specialization of Tumor Lymphatics
-
批准号:6953006
-
项目类别:
-
资助金额:$18.07万
-
财政年份:2005
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
HOMING PEPTIDES FOR THE VASCULATURE IN PROSTATE
-
批准号:6958532
-
项目类别:
-
资助金额:$28.34万
-
财政年份:2005
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
Regulation of Apoptosis by Integrins
-
批准号:6866389
-
项目类别:
-
资助金额:$28.65万
-
财政年份:2004
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
Regulation of Apoptosis by Integrins
-
批准号:6772235
-
项目类别:
-
资助金额:$39.16万
-
财政年份:2004
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
Regulation of Apoptosis by Integrins
-
批准号:7197296
-
项目类别:
-
资助金额:$27.17万
-
财政年份:2004
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
Regulation of Apoptosis by Integrin
-
批准号:6989472
-
项目类别:
-
资助金额:$20.5万
-
财政年份:2004
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
Regulation of Apoptosis by Integrins
-
批准号:7030256
-
项目类别:
-
资助金额:$27.98万
-
财政年份:2004
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
-
批准号:32000851
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:乔安娜
-
依托单位: